Abbott Laboratories Free Cash Flow 2010-2023 | ABT
Abbott Laboratories annual/quarterly free cash flow history and growth rate from 2010 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Abbott Laboratories free cash flow for the quarter ending December 31, 2023 was 5,059.00, a year-over-year.
- Abbott Laboratories free cash flow for the twelve months ending December 31, 2023 was , a year-over-year.
- Abbott Laboratories annual free cash flow for 2023 was $5.059B, a 35.17% decline from 2022.
- Abbott Laboratories annual free cash flow for 2022 was $7.804B, a 9.76% decline from 2021.
- Abbott Laboratories annual free cash flow for 2021 was $8.648B, a 51.08% increase from 2020.
| Abbott Laboratories Annual Free Cash Flow | |
|---|---|
| 2023 | 5,059.00 |
| 2022 | 7,804.00 |
| 2021 | 8,648.00 |
| 2020 | 5,724.00 |
| 2019 | 4,498.00 |
| 2018 | 4,906.00 |
| 2017 | 4,435.00 |
| 2016 | 2,082.00 |
| 2015 | 1,856.00 |
| 2014 | 2,598.00 |
| 2013 | 2,179.00 |
| 2012 | 7,519.00 |
| 2011 | 7,479.00 |
| 2010 | 7,720.91 |
| 2009 | 6,186.11 |
| Abbott Laboratories Quarterly Free Cash Flow | |
|---|---|
| 2023-12-31 | 5,059.00 |
| 2023-09-30 | 2,776.00 |
| 2023-06-30 | 1,459.00 |
| 2023-03-31 | 763.00 |
| 2022-12-31 | 7,804.00 |
| 2022-09-30 | 6,088.00 |
| 2022-06-30 | 3,775.00 |
| 2022-03-31 | 1,744.00 |
| 2021-12-31 | 8,648.00 |
| 2021-09-30 | 6,195.00 |
| 2021-06-30 | 3,955.00 |
| 2021-03-31 | 2,240.00 |
| 2020-12-31 | 5,724.00 |
| 2020-09-30 | 2,605.00 |
| 2020-06-30 | 1,035.00 |
| 2020-03-31 | 355.00 |
| 2019-12-31 | 4,498.00 |
| 2019-09-30 | 2,516.00 |
| 2019-06-30 | 969.00 |
| 2019-03-31 | 377.00 |
| 2018-12-31 | 4,906.00 |
| 2018-09-30 | 3,608.00 |
| 2018-06-30 | 1,779.00 |
| 2018-03-31 | 833.00 |
| 2017-12-31 | 4,435.00 |
| 2017-09-30 | 3,140.00 |
| 2017-06-30 | 1,398.00 |
| 2017-03-31 | 302.00 |
| 2016-12-31 | 2,082.00 |
| 2016-09-30 | 1,231.00 |
| 2016-06-30 | 326.00 |
| 2016-03-31 | -336.00 |
| 2015-12-31 | 1,856.00 |
| 2015-09-30 | 1,276.00 |
| 2015-06-30 | 492.00 |
| 2015-03-31 | -233.00 |
| 2014-12-31 | 2,598.00 |
| 2014-09-30 | 1,647.00 |
| 2014-06-30 | 723.00 |
| 2014-03-31 | 81.00 |
| 2013-12-31 | 2,179.00 |
| 2013-09-30 | 857.00 |
| 2013-06-30 | 612.00 |
| 2013-03-31 | 186.00 |
| 2012-12-31 | 7,519.00 |
| 2012-09-30 | 6,402.07 |
| 2012-06-30 | 3,413.31 |
| 2012-03-31 | 1,771.60 |
| 2011-12-31 | 7,479.00 |
| 2011-09-30 | 6,351.96 |
| 2011-06-30 | 3,749.53 |
| 2011-03-31 | 1,619.33 |
| 2010-12-31 | 7,720.91 |
| 2010-09-30 | 5,695.72 |
| 2010-06-30 | 3,352.39 |
| 2010-03-31 | 1,277.61 |
| 2009-12-31 | 6,186.11 |
| 2009-09-30 | 4,598.94 |
| 2009-06-30 | 1,897.63 |
| 2009-03-31 | 446.57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $182.209B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $125.934B | 30.16 |
| Medtronic (MDT) | Ireland | $109.997B | 15.57 |
| Boston Scientific (BSX) | United States | $108.110B | 34.43 |
| EssilorLuxottica (ESLOY) | France | $100.536B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.244B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
| ResMed (RMD) | United States | $31.412B | 29.49 |
| Terumo (TRUMY) | Japan | $25.118B | 35.47 |
| Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.957B | 15.94 |
| Baxter (BAX) | United States | $18.187B | 12.93 |
| Insulet (PODD) | United States | $11.617B | 51.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.025B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.042B | 26.31 |
| BellRing Brands (BRBR) | United States | $7.836B | 36.71 |
| Lantheus Holdings (LNTH) | United States | $5.269B | 13.13 |
| Haemonetics (HAE) | United States | $4.868B | 24.09 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.186B | 12.69 |
| Prestige Consumer Healthcare (PBH) | United States | $3.495B | 16.52 |
| Envista Holdings (NVST) | United States | $3.186B | 13.15 |
| QuidelOrtho (QDEL) | United States | $2.850B | 15.84 |
| Green Thumb Industries (GTBIF) | United States | $2.719B | 53.86 |
| Neogen (NEOG) | United States | $2.671B | 25.69 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.630B | 0.00 |
| ICU Medical (ICUI) | United States | $2.610B | 23.03 |
| TG Therapeutics (TGTX) | United States | $2.569B | 72.26 |
| Agios Pharmaceuticals (AGIO) | United States | $1.874B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.717B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.709B | 50.09 |
| InMode (INMD) | Israel | $1.520B | 8.08 |
| Warby Parker (WRBY) | United States | $1.466B | 0.00 |
| Owens & Minor (OMI) | United States | $1.425B | 12.42 |
| AdaptHealth (AHCO) | United States | $1.285B | 9.57 |
| National Vision Holdings (EYE) | United States | $1.160B | 36.90 |
| AtriCure (ATRC) | United States | $1.061B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.917B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.885B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.711B | 15.13 |
| Quanterix (QTRX) | United States | $0.638B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.628B | 14.77 |
| PetIQ (PETQ) | United States | $0.543B | 17.73 |
| Jin Medical (ZJYL) | China | $0.536B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.487B | 0.00 |
| Surmodics (SRDX) | United States | $0.459B | 28.71 |
| Biote (BTMD) | United States | $0.456B | 8.74 |
| ZimVie (ZIMV) | United States | $0.454B | 38.72 |
| OraSure Technologies (OSUR) | United States | $0.372B | 11.57 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Zynex (ZYXI) | United States | $0.333B | 45.61 |
| Cerus (CERS) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 27.48 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.247B | 15.28 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| Omeros (OMER) | United States | $0.203B | 0.00 |
| Veru (VERU) | United States | $0.195B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
| InterCure (INCR) | Israel | $0.145B | 24.54 |
| Eagleford Energy (GRUSF) | United States | $0.139B | 70.00 |
| FitLife Brands (FTLF) | United States | $0.138B | 22.22 |
| Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
| Fonar (FONR) | United States | $0.107B | 9.17 |
| MariMed (MRMD) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Safety Shot (SHOT) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.85 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 14.08 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.027B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 74.77 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |